Second signals for cancer immunotherapy.
Saved in:
| Title: | Second signals for cancer immunotherapy. |
|---|---|
| Authors: | Olejniczak SH; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com., Lotze MT; Departments of Surgery, Immunology, and Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com., Skokos D; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Sep 23; Vol. 13 (9). Date of Electronic Publication: 2025 Sep 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40992782 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Second signals for cancer immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Olejniczak+SH%22">Olejniczak SH</searchLink>; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com.<br /><searchLink fieldCode="AU" term="%22Lotze+MT%22">Lotze MT</searchLink>; Departments of Surgery, Immunology, and Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com.<br /><searchLink fieldCode="AU" term="%22Skokos+D%22">Skokos D</searchLink>; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Sep 23; Vol. 13 (9). <i>Date of Electronic Publication: </i>2025 Sep 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40992782 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/jitc-2024-010530 Languages: – Code: eng Text: English Titles: – TitleFull: Second signals for cancer immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Olejniczak SH – PersonEntity: Name: NameFull: Lotze MT – PersonEntity: Name: NameFull: Skokos D IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 09 Text: 2025 Sep 23 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2051-1426 Numbering: – Type: volume Value: 13 – Type: issue Value: 9 Titles: – TitleFull: Journal for immunotherapy of cancer Type: main |
| ResultId | 1 |
